Lacosamid Al

Lacosamide, the active ingredient in Lacosamid Al, is an anticonvulsant presented as an oral formulation for oral use. It treats partial‑onset seizures and epilepsy in adults and children.

GNH USA supplies Lacosamid Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is used as an adjunctive therapy for seizure disorders, acting on neuronal excitability to reduce seizure frequency.

- Partial‑onset seizures: decreases the number of seizures experienced by patients. - Focal epilepsy: provides adjunctive control of focal seizure activity. - Refractory focal seizures: offers an additional option when other antiepileptics are insufficient.

Lacosamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Nausea - Fatigue - Headache

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or other severe skin reactions - Cardiac arrhythmia, including PR‑interval prolongation - Suicidal thoughts or behavior

Before initiating therapy, several safety considerations should be reviewed.

- Renal impairment: assess renal function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Concomitant CNS depressants: may increase sedation; observe patient closely. - History of cardiac arrhythmia: obtain baseline ECG and monitor periodically. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Lacosamide can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower lacosamide plasma concentrations. - Phenytoin: may reduce lacosamide levels. - Primidone: may decrease lacosamide exposure.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may enhance sedation. - Alcohol: can increase central nervous system effects. - Antidepressants (e.g., SSRIs): monitor for increased dizziness or somnolence.